Related Experiment Video
Updated: Aug 8, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Interferon-induced modulation of human ras oncogene expression
Abstract:
Treatment of NIH 3T3 cells with interferon (IFN) after transfection with human bladder carcinoma EJ/T24 c-Ha-ras1 oncogene DNA caused inhibition of ras-induced cell transformation. Furthermore, the effect of IFN on oncogene expression in an established tumor line was studied. A tumor line of NIH 3T3 (RS485) was transformed by human c-Ha-ras1 activated by a viral long terminal repeat. Treatment of the tumor cells with IFN was associated with a progressive appearance of reverted, flat colonies which exhibited a normal phenotype with respect to morphology and growth. The revertants were well spread, contact inhibited cells; they did not grow in soft agar and were not tumorigenic in nude mice. Revertants retained their normal phenotype, although they contained transfecting human c-Ha-ras1 DNA; but, they produced significantly decreased levels of the onc-encoded protein p21 and c-Ha-ras1 mRNA as compared to RS485 cells.
Insights
Interferon (IFN) treatment reversed ras oncogene-induced cell transformation. This resulted in reverted tumor cells with normal morphology and growth, demonstrating reduced oncogene expression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cell transformation by oncogenes like c-Ha-ras1 drives cancer development.
- Interferon (IFN) is known for its anti-proliferative and anti-viral effects.
- Understanding how IFN impacts oncogene expression is crucial for cancer therapy.
Purpose of the Study:
- To investigate the effect of interferon (IFN) on ras oncogene-induced cell transformation.
- To analyze the impact of IFN on oncogene expression in established tumor cells.
Main Methods:
- NIH 3T3 cells were transfected with human bladder carcinoma c-Ha-ras1 oncogene DNA.
- Transfected cells and an established tumor line (RS485) were treated with IFN.
- Phenotypic reversion, cell morphology, growth characteristics, soft agar colony formation, and tumorigenicity in nude mice were assessed.
- Levels of c-Ha-ras1 mRNA and the onc-encoded protein p21 were quantified.
Main Results:
- IFN treatment inhibited ras-induced cell transformation in NIH 3T3 cells.
- IFN treatment of RS485 tumor cells led to the emergence of reverted colonies with normal morphology and growth.
- Revertant cells exhibited contact inhibition, failed to grow in soft agar, and were non-tumorigenic in nude mice.
- Revertant cells showed significantly decreased levels of c-Ha-ras1 mRNA and p21 protein compared to parental RS485 cells, despite retaining the transfected oncogene.
Conclusions:
- Interferon (IFN) can reverse oncogene-induced cell transformation and suppress the malignant phenotype.
- IFN treatment downregulates the expression of the c-Ha-ras1 oncogene and its encoded protein p21.
- These findings suggest a potential therapeutic role for IFN in cancers driven by ras oncogene activation.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Related Concept Videos
Experimental RNAi
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Inhibitors of Viral Protein Synthesis